Australia's Hydration Pharmaceuticals soars 144% on asset sale to US co
** Hydration Pharmaceuticals HPC.AX soars as much as
144.4% to A$0.022; logs biggest-ever intraday pct gain
** Stock hits highest since Jan. 23
** Co divests entire non-U.S. assets to U.S-based Prestige
Consumer Healthcare PBH.N for about $9.5 mln
** Says divestment will help repay ~$6 mln debt, create new
capital to drive sales from U.S. ops
** Around 837,656 shares traded, 3.6x the 30-day avg
** Stock down ~12.5%
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
Recent news on Hydration Pharmaceuticals
See all newsBrief: Hydration Pharmaceuticals Launches Pro Rata Entitlement Offer To Raise Up To A$1.43 MLN
Australia's Hydration Pharmaceuticals soars on upbeat monthly sales
Australia's Hydration Pharmaceuticals soars 144% on asset sale to US co
Brief: Hydration Pharmaceuticals Announces Divesture Of Hydralyte's Non-US Assets
Brief: Hydration Pharmaceuticals Says Adem Karafili Appointed Non-Executive Chairman